42nd Annual Meeting of the American Aging Association

描述（由申请人提供）：本申请要求资金支持2013年美国老龄化协会第42届年会（年龄）将在喜来登酒店，内港在巴尔的摩，马里兰州5月31日至6月3日举行。由于在过去几年中，与老龄化的有害方面作斗争的有希望的战略大量增加，会议的主题将是“老龄化：预防、抑制和减缓”。LaDora Thompson博士、AGE计划委员会（Thompson博士、Brown-Borg博士、Forster博士）、AGE执行委员会（Bickford博士、Harman博士、Ingram博士、Buffenstein博士、沿着Thompson博士、Brown-Borg博士和Forster博士）和会议主席组织科学计划。我们的目标是提供资金，以支持受邀演讲者和初级科学家（博士后研究员，研究生，或新的，初级教师）谁将受益于会议并为会议做出贡献。我们邀请的演讲者在衰老的分子和细胞生物学，衰老生理学，衰老遗传学，实验技术开发和医疗保健问题方面的研究得到国际认可。这些演讲者被认为是他们的科学，谁刺激，并参与，热烈的讨论强大的传播者。近年来，大量的遗传学、药理学、 已经描述了饮食干预和基于运动的干预，其在从单细胞生物到人类的各种系统中减缓衰老。因此，选择这些主题的理由是，调查干预措施的模型系统的结果显著趋同。主题包括-长寿和健康跨度：从苍蝇到人类的教训;肌肉减少症：预防，逆转和减缓的策略;骨质减少症：预防，逆转和减缓的策略;减缓衰老的步伐：模拟物的作用;饮食干预在预防，逆转和减缓生物衰老过程中的影响;从工作台到床边到医疗保健;防止生物衰老和疾病的机制;和研究衰老和健康的新兴技术。会议的目标包括：利用C。为了聚集基础科学家，临床科学家和其他有兴趣预防的观众，逆转，和/或减缓衰老，以强调综合和转化研究成果作为一种手段，开发新的未来途径的治疗选择;建立一个论坛，就“预防、扭转和减缓”生物老化过程的问题自由交流意见，采用多种形式鼓励交流意见;支持已建立的科学家，初级独立研究人员，研究生和博士后实习生;评估会议在实现其既定目标方面的有效性。我预计，本次会议传统上特有的学院和合作气氛将为智力发展和新疗法的讨论提供完美的环境。

DESCRIPTION (provided by applicant): This application requests funds to support the 2013 American Aging Association 42nd Annual Meeting (AGE) to be held at the Sheraton Hotel, Inner Harbor in Baltimore, MD on May 31-June 3rd. Because promising strategies to combat the detrimental aspects of aging have increased substantially over the past years, the theme of the meeting will be "Aging: Prevention, Reversal and Slowing". Dr. LaDora Thompson, AGE Program Committee (Drs. Thompson, Brown-Borg, Forster), AGE Executive Board (Drs. Bickford, Harman, Ingram, Buffenstein, along with Thompson, Brown-Borg, and Forster), and Session Chairs organize the scientific program. Our aim here is to provide funds to support invited speakers and junior scientists (postdoctoral fellows, graduate students, or new, junior faculty) who would benefit from and contribute to the conference. The speakers we invited are internationally recognized for their research on the molecular and cellular biology of aging, physiology of aging, genetics of aging, experimental technology development, and healthcare issues. These speakers are known to be strong communicators of their science, who stimulate, and participate in, lively discussion. In recent years, a large number of genetic, pharmacological, dietary interventions and exercise-based interventions have been described that slow- down aging in various systems ranging from unicellular organisms to humans. Therefore, the rationale behind the choice of these topics is the remarkable convergence of the results from the model systems to investigate interventions. Topics include- Longevity and Health span: Lessons From Flies to Humans; Sarcopenia: Strategies for Preventing, Reversing, and Slowing; Osteopenia: Strategies for Preventing, Reversing, and Slowing; Slow the pace of aging: Role of Mimetics; Impact of Dietary Interventions in Preventing, Reversing, and Slowing Biological Aging Processes; Bench to Bedside to Healthcare; Mechanisms to Protect Against Biological Aging and Disease; and Emerging Technologies for Studying Aging and Health span. The goals of the conference include: To assemble a team of leading thinkers on the subject of 'preventing, reversing and slowing' biological aging processes, using experimental models from C. elegans to humans, to consider important conceptual paradigms and potential interventions; To assemble an audience of basic scientists, clinical scientists and others with an interest in preventing, reversing, and/or slowing aging in order to emphasize integrative and translational research findings as a means to develop novel future avenues for therapeutic options; To create a forum for free exchange of ideas on the subject of 'preventing, reversing and slowing' biological aging processes, using several formats to encourage exchange of ideas; To support established scientists, junior independent investigators, graduate students, and post-doctoral trainees; To evaluate the effectiveness of the conference in achieving its' stated objectives. It i anticipated that the collegial and cooperative atmosphere that has traditionally characterized this meeting will provide the perfect setting for the intellectual development and discussion of novel therapeutics.